Baron Fund Adds to Danaher Stake After 2.6% Q4 Return
Baron Durable Advantage Fund returned 2.6% in Q4 2025 and 16.6% while adding to its stake in Danaher Corporation for its life sciences tools business. Danaher shares closed at $219.98 on February 11, fell 8.3% over one month, rose 8.05% over twelve months, and carry a $155.5 billion market cap.
1. Fund Performance
Baron Durable Advantage Fund recorded a 2.6% gain in the fourth quarter of 2025, matching the S&P 500’s 2.7%, and delivered a 16.6% return for the full year, trailing the S&P 500’s 17.9% but outpacing its Morningstar Large Growth peer group average of 16.1%.
2. Danaher Stock Metrics
Danaher Corporation operates through Biotechnology, Life Sciences and Diagnostics segments, supplying tools for genomics, bioprocessing and clinical diagnostics, and its shares closed at $219.98 on February 11. The stock fell 8.3% over the past month, gained 8.05% over twelve months and carries a $155.5 billion market capitalization.
3. Fund’s Rationale
The fund increased its Danaher position citing constrained biotechnology funding, NIH grant cutbacks and pricing pressure from volume-based procurement in China, while highlighting Danaher’s competitive advantages in life sciences instrumentation and diagnostic platforms as long-term growth drivers.